Literature DB >> 25620669

SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration.

Zbigniew Mikulski1, Rebecca Johnson2, Iftach Shaked1, Gisen Kim3, Heba Nowyhed1, Wendy Goodman4, Grzegorz Chodaczek1, Theresa T Pizarro4, Fabio Cominelli5, Klaus Ley6.   

Abstract

BACKGROUND & AIMS: The lymphatic chemokine CCL21 is required for dendritic cell (DC) migration from tissues to lymph nodes, which helps establish tolerance to foreign yet harmless antigens. We demonstrate that CCL21 is almost completely absent from SAMP1/YitFc (SAMP) mice, which spontaneously develop chronic ileitis that resembles Crohn's disease, and that DC migration is severely impaired in these mice compared with AKR mice (controls). Toll-like receptor agonists like the Toll-like receptor 7 agonist R848 induce DC maturation and mobilization.
METHODS: We collected intestinal and other tissues and mesenteric lymph nodes (MLN) from SAMP mice. Expression of CCL21 was measured by quantitative reverse transcription polymerase chain reaction and immunofluorescence analyses; spontaneous and induced migration of DCs were assessed by flow cytometry. We analyzed production of retinoic acid by DCs and their ability to induce development of regulatory T cells. Mice were fed R848 to determine its effects on migration of DCs and development of ileitis in SAMP mice.
RESULTS: SAMP mice expressed almost no CCL21 in any tissue tested. Their CD11b(+)CD103(+) DCs were defective in migration from the ileal lamina propria to the MLN. DCs from SAMP mice also had a greatly reduced ability to produce retinoic acid and induce development of regulatory T cells compared with control mice. Young SAMP mice had reduced CCL21 expression and decreased DC migration before developing ileitis. Administration of R848 to adult SAMP mice increased migration of DC to the MLN and development of regulatory T cells there, and reduced the severity of ileitis.
CONCLUSIONS: Loss of CCL21 signaling and DC migration is required for development of ileitis in SAMP mice. Reagents such as R848, which activate DC migration to the MLN, may be developed as treatments for patients with Crohn's disease.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD; Immune Regulation; Oral Tolerance; Small Intestine

Mesh:

Substances:

Year:  2015        PMID: 25620669      PMCID: PMC4375031          DOI: 10.1053/j.gastro.2015.01.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  51 in total

1.  Regulation of homeostatic chemokine expression and cell trafficking during immune responses.

Authors:  Scott N Mueller; Karoline A Hosiawa-Meagher; Bogumila T Konieczny; Brandon M Sullivan; Martin F Bachmann; Richard M Locksley; Rafi Ahmed; Mehrdad Matloubian
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

2.  CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease.

Authors:  Sa'ad Y Salim; Manuel A Silva; Asa V Keita; Marie Larsson; Peter Andersson; Karl-Eric Magnusson; Mary H Perdue; Johan D Söderholm
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

3.  The forgotten role of lymphangitis in Crohn's disease.

Authors:  H J Van Kruiningen; Jean-Frédéric Colombel
Journal:  Gut       Date:  2008-01       Impact factor: 23.059

4.  Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections.

Authors:  Heike Unsoeld; Katja Mueller; Ulrike Schleicher; Christian Bogdan; Jörg Zwirner; David Voehringer; Hanspeter Pircher
Journal:  Int Immunol       Date:  2007-10-03       Impact factor: 4.823

Review 5.  CCR7 and its ligands: balancing immunity and tolerance.

Authors:  Reinhold Förster; Ana Clara Davalos-Misslitz; Antal Rot
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

6.  Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation.

Authors:  Daniele Corridoni; Tomohiro Kodani; Alexander Rodriguez-Palacios; Theresa T Pizarro; Wei Xin; Kourtney P Nickerson; Christine McDonald; Klaus F Ley; Derek W Abbott; Fabio Cominelli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

7.  Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells.

Authors:  Tim Worbs; Ulrike Bode; Sheng Yan; Matthias W Hoffmann; Gabriele Hintzen; Günter Bernhardt; Reinhold Förster; Oliver Pabst
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

8.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Authors:  Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

9.  All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.

Authors:  Micah J Benson; Karina Pino-Lagos; Mario Rosemblatt; Randolph J Noelle
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

10.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  7 in total

1.  Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease.

Authors:  Gwendalyn J Randolph; Shashi Bala; Jean-François Rahier; Michael W Johnson; Peter L Wang; ILKe Nalbantoglu; Laurent Dubuquoy; Amélie Chau; Benjamin Pariente; Alex Kartheuser; Bernd H Zinselmeyer; Jean-Frederic Colombel
Journal:  Am J Pathol       Date:  2016-10-13       Impact factor: 4.307

2.  Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.

Authors:  Rafael S Czepielewski; Emma C Erlich; Emily J Onufer; Shannon Young; Brian T Saunders; Yong-Hyun Han; Mary Wohltmann; Peter L Wang; Ki-Wook Kim; Shashi Kumar; Chyi-Song Hsieh; Joshua P Scallan; Ying Yang; Bernd H Zinselmeyer; Michael J Davis; Gwendalyn J Randolph
Journal:  Immunity       Date:  2021-11-16       Impact factor: 31.745

Review 3.  IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions.

Authors:  Michelle A Williams; Amy O'Callaghan; Sinéad C Corr
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 4.  Sex-based differences in inflammatory bowel diseases: a review.

Authors:  Sheila D Rustgi; Maia Kayal; Shailja C Shah
Journal:  Therap Adv Gastroenterol       Date:  2020-04-28       Impact factor: 4.409

5.  Gut Helicobacter presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation.

Authors:  Emilie V Russler-Germain; Jaeu Yi; Shannon Young; Katherine Nutsch; Harikesh S Wong; Teresa L Ai; Jiani N Chai; Vivek Durai; Daniel H Kaplan; Ronald N Germain; Kenneth M Murphy; Chyi-Song Hsieh
Journal:  Elife       Date:  2021-02-03       Impact factor: 8.140

Review 6.  Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.

Authors:  Ludovica F Buttó; Monika Schaubeck; Dirk Haller
Journal:  Front Immunol       Date:  2015-11-19       Impact factor: 7.561

Review 7.  Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?

Authors:  Fabio Cominelli; Kristen O Arseneau; Alexander Rodriguez-Palacios; Theresa T Pizarro
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.